Recombinant Human Filamin-A (FLNA), partial - CD BioSciences

service-banner

Recombinant Human Filamin-A (FLNA), partial

Recombinant Human Filamin-A (FLNA), partial

SPP-01918

Size Price
1 mg Online Inquiry
100 μg Online Inquiry
20 μg Online Inquiry
Target Information
Species Homo sapiens
Target Name Filamin A
UniProt No. P21333
Subcellular Location Cytoplasm, cell cortex, Cytoplasm, cytoskeleton
Tissue Specificity Ubiquitous.
Gene Abbr. FLNA
Full Name filamin A
Alias ABP-280, ABPX, CSBS, CVD1, FGS2
Introduction Filamins are a family of dimeric actin binding proteins that function as structural components of cell adhesion sites. They also serve as a scaffold for subcellular targeting of signaling molecules. The actin binding domain (α-actinin domain) located at the amino terminus is followed by as many as 24 tandem repeats of about 96 residues and the dimerization domain is located at the carboxy terminus. In addition to actin filaments, filamins associate with other structural and signaling molecules such as β-integrins, Rho/Rac/Cdc42, PKC and the insulin receptor, primarily through the carboxy-terminal dimerization domain. Filamin A, the most abundant, and filamin B are widely expressed isoforms, while filamin C is predominantly expressed in muscle. Filamin A is phosphorylated by PAK1 at Ser2152, which is required for PAK1-mediated actin cytoskeleton reorganization.
Product Details
Product Type Recombinant Protein
Buffer before Lyophilization If the delivery form is liquid, the default storage buffer is Tris/PBS-based buffer, 5%-50% glycerol. Note: If you have any special requirement for the glycerol content, please remark when you place the order.
Storage & Handling
Storage Temp. Store at -20 °C upon receipt unless otherwise instructed.
Handling Aliquoting is necessary for mutiple use. Avoid repeated freeze-thaw cycles.

For research use only. Not intended for any clinical use. No products from CD BioSciences may be resold, modified for resale or used to manufacture commercial products without prior written approval from CD BioSciences.